Detalhe da pesquisa
1.
International initiative for a curated SDHB variant database improving the diagnosis of hereditary paraganglioma and pheochromocytoma.
J Med Genet
; 59(8): 785-792, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452955
2.
EPAS1 Mutations and Paragangliomas in Cyanotic Congenital Heart Disease.
N Engl J Med
; 378(13): 1259-1261, 2018 03 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-29601261
3.
Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study.
Lancet Oncol
; 15(6): 648-55, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24745698
4.
Weakly Supervised Deep Learning Predicts Immunotherapy Response in Solid Tumors Based on PD-L1 Expression.
Cancer Res Commun
; 4(1): 92-102, 2024 01 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38126740
5.
Hypoxia-Inducible Factor 2 Alpha (HIF2α) Inhibitors: Targeting Genetically Driven Tumor Hypoxia.
Endocr Rev
; 44(2): 312-322, 2023 03 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36301191
6.
ACT-Discover: identifying karyotype heterogeneity in pancreatic cancer evolution using ctDNA.
Genome Med
; 15(1): 27, 2023 04 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37081523
7.
Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma.
Nat Commun
; 14(1): 1122, 2023 02 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-36854674
8.
Somatotroph pituitary adenoma with acromegaly and autosomal dominant polycystic kidney disease: SSTR5 polymorphism and PKD1 mutation.
Pituitary
; 15(3): 342-9, 2012 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21744088
9.
Endocrine and Neuroendocrine Tumors Special Issue-Checkpoint Inhibitors for Adrenocortical Carcinoma and Metastatic Pheochromocytoma and Paraganglioma: Do They Work?
Cancers (Basel)
; 14(3)2022 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-35158739
10.
Combined Targeting of Pathogenetic Mechanisms in Pancreatic Neuroendocrine Tumors Elicits Synergistic Antitumor Effects.
Cancers (Basel)
; 14(22)2022 Nov 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36428573
11.
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer.
Nat Med
; 28(10): 2162-2170, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36097219
12.
Risk profiles and penetrance estimations in multiple endocrine neoplasia type 2A caused by germline RET mutations located in exon 10.
Hum Mutat
; 32(1): 51-8, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-20979234
13.
Bone mineral density analysis in patients with primary hyperparathyroidism associated with multiple endocrine neoplasia type 1 after total parathyroidectomy.
Clin Endocrinol (Oxf)
; 72(4): 462-8, 2010 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-19650788
14.
Familial isolated pituitary adenoma: evidence for genetic heterogeneity.
Front Horm Res
; 38: 77-86, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-20616498
15.
Spectrum and prevalence of FP/TMEM127 gene mutations in pheochromocytomas and paragangliomas.
JAMA
; 304(23): 2611-9, 2010 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-21156949
16.
Next-generation sequencing for the genetic screening of phaeochromcytomas and paragangliomas: riding the new wave, but with caution.
Clin Endocrinol (Oxf)
; 80(1): 23-4, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24168015
17.
Dynamic Angiogenic Switch as Predictor of Response to Chemotherapy-Bevacizumab in Patients With Metastatic Colorectal Cancer.
Am J Clin Oncol
; 42(1): 56-59, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29975196
18.
Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study.
Endocr Connect
; 8(3): 289-298, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30763276
19.
Germline mutation landscape of multiple endocrine neoplasia type 1 using full gene next-generation sequencing.
Eur J Endocrinol
; 179(6): 391-407, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30324798
20.
Exome Sequencing of Plasma DNA Portrays the Mutation Landscape of Colorectal Cancer and Discovers Mutated VEGFR2 Receptors as Modulators of Antiangiogenic Therapies.
Clin Cancer Res
; 24(15): 3550-3559, 2018 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29588308